These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17075825

  • 1. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
    Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M, Ide H, Adachi M, Kasama T.
    Arthritis Rheum; 2006 Nov; 54(11):3408-16. PubMed ID: 17075825
    [Abstract] [Full Text] [Related]

  • 2. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 3. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S.
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [Abstract] [Full Text] [Related]

  • 4. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE.
    Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
    [Abstract] [Full Text] [Related]

  • 5. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
    Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K.
    Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
    [Abstract] [Full Text] [Related]

  • 6. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
    Blaschke S, Koziolek M, Schwarz A, Benöhr P, Middel P, Schwarz G, Hummel KM, Müller GA.
    J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
    [Abstract] [Full Text] [Related]

  • 7. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
    Sawai H, Park YW, Roberson J, Imai T, Goronzy JJ, Weyand CM.
    Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
    [Abstract] [Full Text] [Related]

  • 8. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy.
    Salih AM, Nixon NB, Dawes PT, Mattey DL.
    J Rheumatol; 1999 Mar; 26(3):551-5. PubMed ID: 10090161
    [Abstract] [Full Text] [Related]

  • 9. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.
    Odai T, Matsunawa M, Takahashi R, Wakabayashi K, Isozaki T, Yajima N, Miwa Y, Kasama T.
    J Rheumatol; 2009 Jun; 36(6):1158-65. PubMed ID: 19369458
    [Abstract] [Full Text] [Related]

  • 10. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
    Volin MV, Huynh N, Klosowska K, Chong KK, Woods JM.
    Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS.
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [Abstract] [Full Text] [Related]

  • 12. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
    Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J.
    J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
    Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H.
    J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
    [Abstract] [Full Text] [Related]

  • 14. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM.
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
    Wakabayashi K, Otsuka K, Sato M, Takahashi R, Odai T, Isozaki T, Yajima N, Miwa Y, Kasama T.
    Mod Rheumatol; 2012 Feb; 22(1):59-65. PubMed ID: 21607712
    [Abstract] [Full Text] [Related]

  • 16. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD.
    Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
    [Abstract] [Full Text] [Related]

  • 17. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis.
    van Gaalen FA, Toes RE, Ditzel HJ, Schaller M, Breedveld FC, Verweij CL, Huizinga TW.
    Arthritis Rheum; 2004 Feb; 50(2):395-9. PubMed ID: 14872481
    [Abstract] [Full Text] [Related]

  • 18. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [Abstract] [Full Text] [Related]

  • 19. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S.
    Arch Immunol Ther Exp (Warsz); 2001 Aug; 49(6):423-30. PubMed ID: 11814236
    [Abstract] [Full Text] [Related]

  • 20. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY, Lan JL, Lin FJ, Hsieh TY.
    Arthritis Rheum; 2005 Jun 15; 53(3):320-7. PubMed ID: 15934126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.